{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 4
    }
  },
  "results": [
    {
      "product_ndc": "71655-578",
      "generic_name": "Ansuvimab",
      "labeler_name": "Emergent BioDefense Operations Lansing LLC",
      "brand_name": "Ebanga",
      "active_ingredients": [
        {
          "name": "ANSUVIMAB",
          "strength": "400 mg/8mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "71655-578-03",
          "description": "1 CARTON in 1 BOX (71655-578-03)  / 36 VIAL, GLASS in 1 CARTON (71655-578-02)  / 8 mL in 1 VIAL, GLASS (71655-578-01)",
          "marketing_start_date": "20201221",
          "sample": false
        },
        {
          "package_ndc": "71655-578-04",
          "description": "4 CARTON in 1 BOX (71655-578-04)  / 36 VIAL, GLASS in 1 CARTON (71655-578-02)  / 8 mL in 1 VIAL, GLASS (71655-578-01)",
          "marketing_start_date": "20201221",
          "sample": false
        },
        {
          "package_ndc": "71655-578-08",
          "description": "8 CARTON in 1 BOX (71655-578-08)  / 36 VIAL, GLASS in 1 CARTON (71655-578-02)  / 8 mL in 1 VIAL, GLASS (71655-578-01)",
          "marketing_start_date": "20201221",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Emergent BioDefense Operations Lansing LLC"
        ],
        "rxcui": [
          "2472156",
          "2472161"
        ],
        "spl_set_id": [
          "de220c8f-ffcb-4522-a6a2-c7d6ce5de1b5"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000194038",
          "N0000194037"
        ],
        "pharm_class_epc": [
          "Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]"
        ],
        "pharm_class_moa": [
          "Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]"
        ],
        "unii": [
          "TG8IQ19NG2"
        ]
      },
      "marketing_category": "BLA",
      "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
      "spl_id": "58f2d4af-2a78-c5f5-e063-6294a90a36bb",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "INTRAVENOUS"
      ],
      "marketing_start_date": "20201221",
      "product_id": "71655-578_58f2d4af-2a78-c5f5-e063-6294a90a36bb",
      "application_number": "BLA761172",
      "brand_name_base": "Ebanga",
      "pharm_class": [
        "Zaire Ebolavirus Glycoprotein-directed Antibody Interactions [MoA]",
        "Zaire Ebolavirus Glycoprotein-directed Antibody [EPC]"
      ]
    }
  ]
}